Annual Drug Patent Expirations for ZYNRELEF+KIT
Zynrelef Kit is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has fifty-three patent family members in nineteen countries.
The generic ingredient in ZYNRELEF KIT is bupivacaine; meloxicam. One supplier is listed for this compound. Additional details are available on the bupivacaine; meloxicam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
